|
|
Volumn 68, Issue 5, 2015, Pages 912-914
|
|
Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
CARBOPLATIN;
FANCONI ANEMIA GROUP L PROTEIN;
GEMCITABINE;
HEMOGLOBIN;
MAMMALIAN TARGET OF RAPAMYCIN;
MORPHINE;
NIVOLUMAB;
PROGRAMMED DEATH 1 RECEPTOR;
SUNITINIB;
VASCULOTROPIN;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
ADULT;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER PALLIATIVE THERAPY;
CASE REPORT;
CELL DEDIFFERENTIATION;
COMPUTER ASSISTED TOMOGRAPHY;
CYTOTOXICITY;
GENOMICS;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HUMAN TISSUE;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
LETTER;
LUNG BIOPSY;
LUNG NODULE;
MALE;
NIGHT SWEAT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PAPILLARY CARCINOMA;
PAPILLARY RENAL CELL CARCINOMA;
PBRM1 GENE;
PRIORITY JOURNAL;
PROTEIN TARGETING;
RHABDOID TUMOR;
SARCOMATOID CARCINOMA;
SINGLE DRUG DOSE;
THROMBOCYTOSIS;
TREATMENT RESPONSE;
TUMOR SUPPRESSOR GENE;
YOUNG ADULT;
BONE NEOPLASMS;
CARCINOMA, RENAL CELL;
KIDNEY NEOPLASMS;
LUNG NEOPLASMS;
PATHOLOGY;
RADIOGRAPHY;
SECONDARY;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
CARCINOMA, RENAL CELL;
HUMANS;
KIDNEY NEOPLASMS;
LUNG NEOPLASMS;
MALE;
|
|
EID: 84942992080
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2015.07.008 Document Type: Letter |
|
Times cited : (52)
|
|
References (6)
|
